10 Increased By 1 To Replace Real Estate &Nbsp; Tibet Pharmaceutical "Fight" Compromise Ends.

Tibet pharmaceutical industry has argued for more than two years of the follow-up plan of share reform. Today, there is a new result. The company intends to add additional shares to the all circulating shareholders in the capital reserve fund, increasing the proportion to 1 shares per 10 shares.

According to the announcement of the Tibet pharmaceutical industry today, the board of directors deliberated and adopted the "follow up arrangement plan of Tibet nudikang pharmaceutical company's share splitting reform plan". With the implementation of this scheme, the total number of tradable shares of the unlimited sale conditions on the stock registration day is the base number, and all the unconditional tradable shareholders will add additional shares to the capital reserve fund, and the additional proportion will be increased to 1 shares in every 10 shares of the 68 million 790 thousand listed companies.

After the completion of this scheme, the total share capital of the company increased to 145 million 589 thousand shares, of which the total number of tradable shares with unlimited sale conditions was 75 million 669 thousand shares, which accounted for 49.59% of the total share capital of the company from 51.97% to 51.97%.

At the same time, the relevant plan on the subsequent arrangements for stock reform which was adopted in August 13, 2007 was no longer implemented.

According to the original plan, 1 months after the implementation of the share reform plan and the pfer of new Phoenix's pferable shares, the Tibet pharmaceutical industry will start the new purchase of assets by Phoenix Pharmaceutical Group and its controlling shareholder, Fenghuang group. The assets will be injected into the 2 real estate projects of Phoenix Mountain's "C area" and "Zhongguancun science and Technology Park Hot Spring Industrial Park".

In January 28, 2008, the new Phoenix pferee pfer procedures were completed.

However, since the real estate market situation has changed significantly compared with the share reform, the major shareholders of the company failed to form a consensus on the proposed assets injection project, and there was no substantive progress in the subsequent arrangements for the share reform.

The Tibet pharmaceutical industry has launched a new plan, leaving the real estate asset injection, or the compromise between new and old shareholders.

However, abandoning the private placement scheme is obviously not conducive to the consolidation of Phoenix.

In January 2008, Huaxi pharmaceutical group pferred the 38 million 440 thousand shares of the Tibet pharmaceutical industry to Beijing new Phoenix Real Estate Development Co., Ltd. and its concerted action. The latter held 34 million 960 thousand shares of Tibet pharmaceutical company, accounting for 25.2% of the total share capital of the company, and became the largest shareholder in fact, while the western medicine industry ranked 22.69% as the largest single shareholder.

The new and old shareholders have different opinions on many decisions of the board of directors, which also leads to the difficulty of pushing forward the subsequent arrangements for share reform and the issuance of private placements. The new scheme has maintained a state of equal balance between the two sides.